BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 14946321)

  • 1. Studies on the inhibition of proteolytic enzymes by serum. I. The mechanism of the inhibition of trypsin, plasmin, and chymotrypsin by serum using fibrin tagged with I131 as a substrate.
    SHULMAN NR
    J Exp Med; 1952 Jun; 95(6):571-91. PubMed ID: 14946321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the inhibition of proteolytic enzymes by serum. III. Physiological aspects of variations in proteolytic inhibition. The concurrence of changes in fibrinogen concentration with changes in trypsin inhibition.
    SHULMAN NR
    J Exp Med; 1952 Jun; 95(6):605-18. PubMed ID: 14946323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the inhibition of proteolytic enzymes by serum. II. Demonstration that separate proteolytic inhibitors exist in serum; their distinctive properties and the specificity of their action.
    SHULMAN NR
    J Exp Med; 1952 Jun; 95(6):593-603. PubMed ID: 14946322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of non cross-linked and cross-linked fibrin clots by plasmin, trypsin, chymotrypsin and Brinase.
    Gormsen J; Feddersen C
    Thromb Res; 1974 Aug; 5(2):125-39. PubMed ID: 4278050
    [No Abstract]   [Full Text] [Related]  

  • 5. Degradation of fibrinogen by proteolytic enzymes. II. Effect of the products on coagulation.
    Miller SP; Sanchez-Avalos J
    Thromb Diath Haemorrh; 1968 Nov; 20(1):15-30. PubMed ID: 4236936
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of streptococcal fibrinolysis; the dissimilarity of serum protease and trypsin as indicated by the separate specificities of their kinases, fibrinolysin and enterokinase.
    KAPLAN MH
    J Clin Invest; 1946 May; 25():331-6. PubMed ID: 20986038
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional evaluation of the structural features of proteases and their substrate in fibrin surface degradation.
    Kolev K; Tenekedjiev K; Komorowicz E; Machovich R
    J Biol Chem; 1997 May; 272(21):13666-75. PubMed ID: 9153217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carboxylic and amino acids on fibrinolysis produced by plasmin, plasminogen activator and proteases.
    MULLERTZ S
    Proc Soc Exp Biol Med; 1954 Feb; 85(2):326-9. PubMed ID: 13155587
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood coagulating properties of immobilized proteases].
    Zubairov DM; Zinkevich OD
    Vopr Med Khim; 1976; 22(2):187-91. PubMed ID: 140525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin.
    Edy J; Collen D
    Biochim Biophys Acta; 1977 Oct; 484(2):423-32. PubMed ID: 143966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
    Cheng AC; Tsai IH
    Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of proteolytic enzymes on fibrin stabilizing factor.
    Kopeć M; Latallo ZS; Stahl M; Wegrzynowicz Z
    Biochim Biophys Acta; 1969 Jul; 181(2):437-45. PubMed ID: 4239917
    [No Abstract]   [Full Text] [Related]  

  • 13. [Structure of fibrinogen in view of the properties and structure of proteolytic products of degradation by plasmin].
    Budzyński AZ
    Postepy Hig Med Dosw; 1969; 23(3):293-369. PubMed ID: 4240986
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hydrolysis of polymeric fibrin by plasmin, miniplasmin, microplasmin and trypsin].
    Andrianov SI; Makogonenko EM; Kudinov SA
    Ukr Biokhim Zh (1978); 1992; 64(3):14-20. PubMed ID: 1440960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STABILITY OF PANCREATIC DEOXYRIBONUCLEASE IN THE PRESENCE OF PROTEASES.
    MAXWELL RE; NICKEL VS; LEWANDOWSKI V
    J Pharm Sci; 1963 Aug; 52():796-7. PubMed ID: 14060465
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on proteolytic enzymes. I. Toxicology of crystalline trypsin and chymotrypsin.
    HENDLEY CD; ROBBINS KC; DERTINGER B; CLEMENTS GR; ERCOLI N
    Arch Int Pharmacodyn Ther; 1956 Apr; 106(1-2):164-77. PubMed ID: 13328223
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of plasmin by fibrinogen.
    Higazi AA; Mayer M
    Biochem J; 1990 Jul; 269(2):299-302. PubMed ID: 2143650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [INHIBITORS OF PROTEOLYTIC ENZYMES IN PURPURA].
    FIEHRER A
    Rev Pathol Gen Physiol Clin; 1963 Jul; 63():769-71. PubMed ID: 14090124
    [No Abstract]   [Full Text] [Related]  

  • 19. EFFECT OF PLASMIN ON FIBRINOGEN AND FIBRIN.
    GAJEWSKI J; ALEXANDER B
    Am J Physiol; 1964 Jan; 206():79-82. PubMed ID: 14111457
    [No Abstract]   [Full Text] [Related]  

  • 20. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.